» Articles » PMID: 11110302

Influence of Bubble Size Distribution on the Echogenicity of Ultrasound Contrast Agents: a Study of SonoVue

Overview
Journal Invest Radiol
Specialty Radiology
Date 2000 Dec 8
PMID 11110302
Citations 67
Authors
Affiliations
Soon will be listed here.
Abstract

Rationale And Objectives: To study the relative contributions of different bubble size classes to SonoVue's echogenicity in fundamental acoustic imaging modes. SonoVue is a contrast agent, previously known as BR1, with a bubble size distribution extending from approximately 0.7 to 10 microm.

Methods: A model for the acoustic response of SonoVue was determined and validated for a set of experimental data. This model was used to simulate the acoustic response of a standard batch of SonoVue as the sum of responses of non-overlapping bubble size classes.

Results: The simulation was first validated for a standard SonoVue bubble size distribution. When this distribution was considered as five size classes with equal numbers of bubbles, it was found that bubbles smaller than 2 microm accounted for 60% of the total number but contained only 5% of the total gas volume. The simulation results indicated marked differences in the acoustic contributions from these classes, with 80% of the acoustic efficacy provided by bubbles 3 to 9 microm in diameter. The study also compared bubble distributions in number, surface, and volume, with the distribution computed in terms of acoustic efficacy.

Conclusions: This study shows why bubble volume is a much better indicator of SonoVue's efficacy than is bubble count. A low threshold in diameter was found for SonoVue microbubbles at approximately 2 microm, under which size bubbles do not contribute appreciably to the echogenicity at medical ultrasound frequencies.

Citing Articles

The Compression-Dominated Ultrasound Response of Poly(-butyl cyanoacrylate) Hard-Shelled Microbubbles Induces Significant Sonoporation and Sonopermeation Effects .

Block J, Li H, Collado-Lara G, Kooiman K, Rix A, Chen J ACS Appl Bio Mater. 2025; 8(2):1240-1250.

PMID: 39900350 PMC: 11836932. DOI: 10.1021/acsabm.4c01551.


Methods for Rapid Characterization of Tunable Microbubble Formulations.

Harpster S, Pineiro A, Wong J Bioengineering (Basel). 2025; 11(12.

PMID: 39768042 PMC: 11673760. DOI: 10.3390/bioengineering11121224.


A retrospective study on adverse events of intravenous administration of sulfur hexafluoride microbubbles in abdominal and superficial applications in 83,778 patients.

Li D, Zhang R, Lan H, Chen M, Huang Z, Zhao H Insights Imaging. 2024; 15(1):65.

PMID: 38411872 PMC: 10899544. DOI: 10.1186/s13244-024-01632-9.


Nanomedicines for Improved Management of Ectopic Pregnancy: A Narrative Review.

Moses A, Korzun T, Mamnoon B, Baldwin M, Myatt L, Taratula O Small. 2023; 20(41):e2301873.

PMID: 37471169 PMC: 10837845. DOI: 10.1002/smll.202301873.


Backscattering amplitude in ultrasound localization microscopy.

Renaudin N, Pezet S, Ialy-Radio N, Demene C, Tanter M Sci Rep. 2023; 13(1):11477.

PMID: 37455266 PMC: 10350458. DOI: 10.1038/s41598-023-38531-w.